Mirum Pharmaceuticals, Inc. (MIRM)
79.57
+0.72
(+0.91%)
USD |
NASDAQ |
Dec 31, 14:42
Mirum Pharmaceuticals Total Liabilities (Quarterly): 493.07M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Arcutis Biotherapeutics, Inc. | 212.90M |
| Insmed, Inc. | 1.415B |
| CorMedix, Inc. | 376.73M |
| ADMA Biologics, Inc. | 137.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 785.12M |
| Shareholders Equity (Quarterly) | 292.05M |
| Debt to Equity Ratio | 1.092 |
| Current Ratio | 3.309 |
| Net Debt Paydown Yield | -0.01% |